Zoetis Inc. Files 10-Q for Q2 2024
Ticker: ZTS · Form: 10-Q · Filed: 2024-08-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, animal health
TL;DR
Zoetis Q2 10-Q is in. Check financials for animal health performance.
AI Summary
Zoetis Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and the first six months of the year. Key financial data and operational details for this period are presented, reflecting the company's performance in the animal health sector.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for Zoetis, a major player in the animal health industry, allowing for informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Players & Entities
- Zoetis Inc. (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240806 (date) — Filing date
FAQ
What were Zoetis's total revenues for the six months ended June 30, 2024?
The filing does not explicitly state total revenues for the six months ended June 30, 2024, but it does provide comparative data for Q2 2024 and Q2 2023, and the first six months of 2024 and 2023.
What is the company's primary industry classification?
Zoetis Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the fiscal year end for Zoetis Inc.?
The fiscal year end for Zoetis Inc. is December 31.
What is the SEC file number for Zoetis Inc.?
The SEC file number for Zoetis Inc. is 001-35797.
What is the business address of Zoetis Inc.?
The business address is 10 SYLVAN WAY, PARSIPPANY, NJ 07054.
From the Filing
0001555280-24-000299.txt : 20240806 0001555280-24-000299.hdr.sgml : 20240806 20240806124147 ACCESSION NUMBER: 0001555280-24-000299 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 241178154 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 10-Q 1 zts-20240630.htm 10-Q zts-20240630 false 2024 Q2 0001555280 12/31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares zts:geographicRegion zts:country zts:specie zts:productCategory zts:product_category xbrli:pure iso4217:EUR iso4217:DKK iso4217:CHF zts:defendant zts:segment 0001555280 2024-01-01 2024-06-30 0001555280 2024-08-02 0001555280 2024-04-01 2024-06-30 0001555280 2023-04-01 2023-06-30 0001555280 2023-01-01 2023-06-30 0001555280 us-gaap:CashFlowHedgingMember 2024-04-01 2024-06-30 0001555280 us-gaap:CashFlowHedgingMember 2023-04-01 2023-06-30 0001555280 us-gaap:CashFlowHedgingMember 2024-01-01 2024-06-30 0001555280 us-gaap:CashFlowHedgingMember 2023-01-01 2023-06-30 0001555280 us-gaap:NetInvestmentHedgingMember 2024-04-01 2024-06-30 0001555280 us-gaap:NetInvestmentHedgingMember 2023-04-01 2023-06-30 0001555280 us-gaap:NetInvestmentHedgingMember 2024-01-01 2024-06-30 0001555280 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-06-30 0001555280 2024-06-30 0001555280 2023-12-31 0001555280 us-gaap:CommonStockMember 2024-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2024-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001555280 us-gaap:RetainedEarningsMember 2024-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2024-03-31 0001555280 2024-03-31 0001555280 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001555280 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001555280 zts:ShareRepurchaseProgramMember us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001555280 us-gaap:CommonStockMember 2024-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2024-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001555280 us-gaap:RetainedEarningsMember 2024-06-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001555280 us-gaap:NoncontrollingInterestMember 2024-06-30 0001555280 us-gaap:CommonStockMember 2023-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001555280 us-gaap:RetainedEarningsMember 2023-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2023-03-31 0001555280 2023-03-31 0001555280 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001555280 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001555280 zts:ShareRepurchaseProgramMember us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001555280 us-gaap:CommonStockMember 2023-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2023-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001555280 us-gaap:RetainedEarni